Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 158

1.

Comparison of the ultrastructural and immunophenotypic characteristics of human umbilical cord-derived mesenchymal stromal cells and in situ cells in Wharton's jelly.

Ryu YJ, Seol HS, Cho TJ, Kwon TJ, Jang SJ, Cho J.

Ultrastruct Pathol. 2013 May;37(3):196-203. doi: 10.3109/01913123.2013.772268.

PMID:
23650992
2.

Isolation of mesenchymal stromal cells from extraembryonic tissues and their characteristics.

Veryasov VN, Savilova AM, Buyanovskaya OA, Chulkina MM, Pavlovich SV, Sukhikh GT.

Bull Exp Biol Med. 2014 May;157(1):119-24. doi: 10.1007/s10517-014-2506-0. Epub 2014 Jun 10.

PMID:
24909727
3.

Immunosuppressive properties of mesenchymal stromal cells derived from amnion, placenta, Wharton's jelly and umbilical cord.

Manochantr S, U-pratya Y, Kheolamai P, Rojphisan S, Chayosumrit M, Tantrawatpan C, Supokawej A, Issaragrisil S.

Intern Med J. 2013 Apr;43(4):430-9. doi: 10.1111/imj.12044.

PMID:
23176558
4.

Characteristics of mesenchymal stem cells derived from Wharton's jelly of human umbilical cord and for fabrication of non-scaffold tissue-engineered cartilage.

Liu S, Hou KD, Yuan M, Peng J, Zhang L, Sui X, Zhao B, Xu W, Wang A, Lu S, Guo Q.

J Biosci Bioeng. 2014 Feb;117(2):229-35. doi: 10.1016/j.jbiosc.2013.07.001. Epub 2013 Jul 27.

PMID:
23899897
5.

Immune characterization of mesenchymal stem cells in human umbilical cord Wharton's jelly and derived cartilage cells.

Liu S, Yuan M, Hou K, Zhang L, Zheng X, Zhao B, Sui X, Xu W, Lu S, Guo Q.

Cell Immunol. 2012 Jul-Aug;278(1-2):35-44. doi: 10.1016/j.cellimm.2012.06.010. Epub 2012 Jul 16.

PMID:
23121974
6.

In vitro differentiation of human umbilical cord mesenchymal stem cells (hUCMSCs), derived from Wharton's jelly, into choline acetyltransferase (ChAT)-positive cells.

Zhang L, Tan X, Dong C, Zou L, Zhao H, Zhang X, Tian M, Jin G.

Int J Dev Neurosci. 2012 Oct;30(6):471-7. doi: 10.1016/j.ijdevneu.2012.05.006. Epub 2012 Jun 5.

PMID:
22683696
7.

Mesenchymal stem cells isolated from peripheral blood and umbilical cord Wharton's jelly.

Trivanović D, Kocić J, Mojsilović S, Krstić A, Ilić V, Djordjević IO, Santibanez JF, Jovcić G, Terzić M, Bugarski D.

Srp Arh Celok Lek. 2013 Mar-Apr;141(3-4):178-86.

8.

Comparison of human mesenchymal stem cells isolated by explant culture method from entire umbilical cord and Wharton's jelly matrix.

Hendijani F, Sadeghi-Aliabadi H, Haghjooy Javanmard S.

Cell Tissue Bank. 2014 Dec;15(4):555-65. doi: 10.1007/s10561-014-9425-1. Epub 2014 Feb 17.

PMID:
24532125
9.

Immunomodulatory effects of human umbilical cord Wharton's jelly-derived mesenchymal stem cells on differentiation, maturation and endocytosis of monocyte-derived dendritic cells.

Saeidi M, Masoud A, Shakiba Y, Hadjati J, Mohyeddin Bonab M, Nicknam MH, Latifpour M, Nikbin B.

Iran J Allergy Asthma Immunol. 2013 Mar;12(1):37-49. doi: 012.01/ijaai.3749.

10.

Promising new potential for mesenchymal stem cells derived from human umbilical cord Wharton's jelly: sweat gland cell-like differentiative capacity.

Xu Y, Huang S, Ma K, Fu X, Han W, Sheng Z.

J Tissue Eng Regen Med. 2012 Aug;6(8):645-54. doi: 10.1002/term.468. Epub 2011 Sep 13.

PMID:
21916019
11.

Immunomodulatory effect of human umbilical cord Wharton's jelly-derived mesenchymal stem cells on lymphocytes.

Zhou C, Yang B, Tian Y, Jiao H, Zheng W, Wang J, Guan F.

Cell Immunol. 2011;272(1):33-8. doi: 10.1016/j.cellimm.2011.09.010. Epub 2011 Sep 29.

12.

Restricted myogenic potential of mesenchymal stromal cells isolated from umbilical cord.

Grabowska I, Brzoska E, Gawrysiak A, Streminska W, Moraczewski J, Polanski Z, Hoser G, Kawiak J, Machaj EK, Pojda Z, Ciemerych MA.

Cell Transplant. 2012;21(8):1711-26. doi: 10.3727/096368912X640493. Epub 2012 Apr 17.

PMID:
22525423
13.

Human umbilical cord Wharton's Jelly-derived mesenchymal stem cells differentiation into nerve-like cells.

Ma L, Feng XY, Cui BL, Law F, Jiang XW, Yang LY, Xie QD, Huang TH.

Chin Med J (Engl). 2005 Dec 5;118(23):1987-93.

PMID:
16336835
14.

Wharton's Jelly stem cells: future clinical applications.

Taghizadeh RR, Cetrulo KJ, Cetrulo CL.

Placenta. 2011 Oct;32 Suppl 4:S311-5. doi: 10.1016/j.placenta.2011.06.010. Epub 2011 Jul 6. Review.

PMID:
21733573
15.

Isolation and characterization of canine Wharton's jelly-derived mesenchymal stem cells.

Seo MS, Park SB, Kang KS.

Cell Transplant. 2012;21(7):1493-502.

PMID:
22732242
16.

Mesenchymal stromal cells of human umbilical cord Wharton's jelly accelerate wound healing by paracrine mechanisms.

Shohara R, Yamamoto A, Takikawa S, Iwase A, Hibi H, Kikkawa F, Ueda M.

Cytotherapy. 2012 Nov;14(10):1171-81. doi: 10.3109/14653249.2012.706705. Epub 2012 Aug 17.

PMID:
22900957
17.

A simple and serum-free protocol for cryopreservation of human umbilical cord as source of Wharton's jelly mesenchymal stem cells.

Roy S, Arora S, Kumari P, Ta M.

Cryobiology. 2014 Jun;68(3):467-72. doi: 10.1016/j.cryobiol.2014.03.010. Epub 2014 Apr 4.

PMID:
24704519
18.

Conversion of human umbilical cord mesenchymal stem cells in Wharton's jelly to dopamine neurons mediated by the Lmx1a and neurturin in vitro: potential therapeutic application for Parkinson's disease in a rhesus monkey model.

Yan M, Sun M, Zhou Y, Wang W, He Z, Tang D, Lu S, Wang X, Li S, Wang W, Li H.

PLoS One. 2013 May 28;8(5):e64000. doi: 10.1371/journal.pone.0064000. Print 2013.

19.

Mesenchymal stem cells derived from Wharton's jelly: comparative phenotype analysis between tissue and in vitro expansion.

Margossian T, Reppel L, Makdissy N, Stoltz JF, Bensoussan D, Huselstein C.

Biomed Mater Eng. 2012;22(4):243-54. doi: 10.3233/BME-2012-0714.

PMID:
22785368
20.

High yield recovery of equine mesenchymal stem cells from umbilical cord matrix/Wharton's jelly using a semi-automated process.

Nazari-Shafti TZ, Bruno IG, Martinez RF, Coleman ME, Alt EU, McClure SR.

Methods Mol Biol. 2015;1235:131-46. doi: 10.1007/978-1-4939-1785-3_12.

PMID:
25388392

Supplemental Content

Support Center